[go: up one dir, main page]

HK1220692A1 - 作為布羅莫結構域抑制劑的苯並咪唑酮衍生物 - Google Patents

作為布羅莫結構域抑制劑的苯並咪唑酮衍生物

Info

Publication number
HK1220692A1
HK1220692A1 HK16108876.4A HK16108876A HK1220692A1 HK 1220692 A1 HK1220692 A1 HK 1220692A1 HK 16108876 A HK16108876 A HK 16108876A HK 1220692 A1 HK1220692 A1 HK 1220692A1
Authority
HK
Hong Kong
Prior art keywords
dimethylisoxazol
benzo
mmol
imidazol
alkyl
Prior art date
Application number
HK16108876.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1220692B (zh
Inventor
Evangelos Aktoudianakis
Gregory CHIN
Britton Kenneth CORKEY
Jinfa Du
Kristyna ELBEL
Robert H. JIANG
Tetsuya Kobayashi
Ruben Martinez
Samuel E. Metobo
Michael Mish
Sophie SHEVICK
David Sperandio
Hai Yang
Jeff Zablocki
Original Assignee
Gilead Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences, Inc. filed Critical Gilead Sciences, Inc.
Publication of HK1220692A1 publication Critical patent/HK1220692A1/zh
Publication of HK1220692B publication Critical patent/HK1220692B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK16108876.4A 2013-03-28 2014-03-27 作為布羅莫結構域抑制劑的苯並咪唑酮衍生物 HK1220692B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361805995P 2013-03-28 2013-03-28
US61/805,995 2013-03-28
US201361860230P 2013-07-30 2013-07-30
US61/860,230 2013-07-30
PCT/US2014/032031 WO2014160873A1 (en) 2013-03-28 2014-03-27 Benzimidazolone derivatives as bromodomain inhibitors

Publications (2)

Publication Number Publication Date
HK1220692A1 true HK1220692A1 (zh) 2017-05-12
HK1220692B HK1220692B (zh) 2018-02-15

Family

ID=

Also Published As

Publication number Publication date
JP2016515584A (ja) 2016-05-30
HRP20170750T1 (hr) 2017-07-28
LT2978759T (lt) 2017-05-25
HUE034772T2 (en) 2018-02-28
UY35516A (es) 2014-09-30
ZA201506356B (en) 2017-08-30
AU2014241152B2 (en) 2016-11-03
ES2626397T3 (es) 2017-07-24
JP6339175B2 (ja) 2018-06-06
BR112015024078A2 (pt) 2017-07-18
EP2978759B1 (en) 2017-03-15
PE20151982A1 (es) 2016-01-28
PL2978759T3 (pl) 2017-08-31
TW201504233A (zh) 2015-02-01
AP2015008741A0 (en) 2015-09-30
MX2015013798A (es) 2016-02-16
US20140296246A1 (en) 2014-10-02
SMT201700249T1 (it) 2017-07-18
CN105102453B (zh) 2018-04-06
DK2978759T3 (da) 2017-06-19
WO2014160873A1 (en) 2014-10-02
AU2014241152A1 (en) 2015-09-17
CY1119165T1 (el) 2018-02-14
PH12015502246A1 (en) 2016-02-01
US9255089B2 (en) 2016-02-09
MD4531B1 (ro) 2017-11-30
KR20150135476A (ko) 2015-12-02
SI2978759T1 (sl) 2017-05-31
CR20150515A (es) 2015-12-01
CL2015002871A1 (es) 2016-05-13
MY176634A (en) 2020-08-19
MD20150104A2 (ro) 2016-02-29
KR101847698B1 (ko) 2018-04-10
CA2907502A1 (en) 2014-10-02
CN105102453A (zh) 2015-11-25
IL241186A0 (en) 2015-11-30
CA2907502C (en) 2018-02-27
RS56050B1 (sr) 2017-09-29
NZ711586A (en) 2016-09-30
PT2978759T (pt) 2017-05-31
EA029497B1 (ru) 2018-04-30
TWI530499B (zh) 2016-04-21
MD4531C1 (ro) 2018-06-30
EP2978759A1 (en) 2016-02-03
EA201591455A1 (ru) 2016-01-29
US20160031868A1 (en) 2016-02-04
SG11201507926RA (en) 2015-10-29

Similar Documents

Publication Publication Date Title
EP2978759B1 (en) Benzimidazolone derivatives as bromodomain inhibitors
JP7373992B2 (ja) 過剰増殖性疾患の治療のための置換ピラゾール化合物およびそれらの使用方法
EP2812001B1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
EP2953941B1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
US20160075695A1 (en) Benzimidazole derivatives as bromodomain inhibitors
EP2935271B1 (en) Novel substituted imidazoles as casein kinase 1 / inhibitors
KR20160101899A (ko) 브로모도메인 억제제
EP3159341B1 (en) Pyridino[1,2-a]pyrimidone analogue used as pi3k inhibitor
JP6283688B2 (ja) カゼインキナーゼ1d/e阻害剤としての新規なピラゾール置換のイミダゾピラジン
EP3475285B1 (en) Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof
HK1220692B (zh) 作為布羅莫結構域抑制劑的苯並咪唑酮衍生物
OA17636A (en) Benzimidazolone derivatives as bromodomain inhibitors
CN118930534A (zh) 含有吲唑的化合物、其药物组合物及其制备方法和用途